nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorprothixene—Midazolam—epilepsy syndrome	0.197	0.529	CrCtD
Chlorprothixene—Diazepam—epilepsy syndrome	0.175	0.471	CrCtD
Chlorprothixene—CHRM3—epilepsy syndrome	0.0654	0.301	CbGaD
Chlorprothixene—CHRM1—epilepsy syndrome	0.061	0.281	CbGaD
Chlorprothixene—CHRM2—epilepsy syndrome	0.0498	0.229	CbGaD
Chlorprothixene—HTR2A—epilepsy syndrome	0.0249	0.115	CbGaD
Chlorprothixene—ABCB1—epilepsy syndrome	0.0163	0.0749	CbGaD
Chlorprothixene—ABCB1—Levetiracetam—epilepsy syndrome	0.0105	0.208	CbGbCtD
Chlorprothixene—ABCB1—Clobazam—epilepsy syndrome	0.00727	0.145	CbGbCtD
Chlorprothixene—Ethyl loflazepate—Clonazepam—epilepsy syndrome	0.007	0.0252	CrCrCtD
Chlorprothixene—ABCB1—Lamotrigine—epilepsy syndrome	0.007	0.139	CbGbCtD
Chlorprothixene—Cinolazepam—Midazolam—epilepsy syndrome	0.00668	0.024	CrCrCtD
Chlorprothixene—Ethyl loflazepate—Midazolam—epilepsy syndrome	0.00668	0.024	CrCrCtD
Chlorprothixene—Chlordiazepoxide—Midazolam—epilepsy syndrome	0.00619	0.0223	CrCrCtD
Chlorprothixene—Nortriptyline—Oxcarbazepine—epilepsy syndrome	0.00619	0.0223	CrCrCtD
Chlorprothixene—ABCB1—Carbamazepine—epilepsy syndrome	0.00603	0.12	CbGbCtD
Chlorprothixene—Cinolazepam—Diazepam—epilepsy syndrome	0.00595	0.0214	CrCrCtD
Chlorprothixene—Ethyl loflazepate—Diazepam—epilepsy syndrome	0.00595	0.0214	CrCrCtD
Chlorprothixene—Chlordiazepoxide—Clobazam—epilepsy syndrome	0.00593	0.0213	CrCrCtD
Chlorprothixene—Triazolam—Clonazepam—epilepsy syndrome	0.00586	0.0211	CrCrCtD
Chlorprothixene—Cyclobenzaprine—Carbamazepine—epilepsy syndrome	0.0057	0.0205	CrCrCtD
Chlorprothixene—Camazepam—Midazolam—epilepsy syndrome	0.00559	0.0201	CrCrCtD
Chlorprothixene—Triazolam—Midazolam—epilepsy syndrome	0.00559	0.0201	CrCrCtD
Chlorprothixene—Doxepin—Oxcarbazepine—epilepsy syndrome	0.00559	0.0201	CrCrCtD
Chlorprothixene—Adinazolam—Midazolam—epilepsy syndrome	0.00559	0.0201	CrCrCtD
Chlorprothixene—Chlordiazepoxide—Diazepam—epilepsy syndrome	0.00552	0.0198	CrCrCtD
Chlorprothixene—Flurazepam—Clonazepam—epilepsy syndrome	0.00551	0.0198	CrCrCtD
Chlorprothixene—Midazolam—Clonazepam—epilepsy syndrome	0.00551	0.0198	CrCrCtD
Chlorprothixene—ABCB1—Phenytoin—epilepsy syndrome	0.0054	0.107	CbGbCtD
Chlorprothixene—Adinazolam—Clobazam—epilepsy syndrome	0.00536	0.0193	CrCrCtD
Chlorprothixene—Camazepam—Clobazam—epilepsy syndrome	0.00536	0.0193	CrCrCtD
Chlorprothixene—Triazolam—Clobazam—epilepsy syndrome	0.00536	0.0193	CrCrCtD
Chlorprothixene—Lorazepam—Clonazepam—epilepsy syndrome	0.00535	0.0192	CrCrCtD
Chlorprothixene—Flurazepam—Midazolam—epilepsy syndrome	0.00525	0.0189	CrCrCtD
Chlorprothixene—Lorazepam—Midazolam—epilepsy syndrome	0.0051	0.0184	CrCrCtD
Chlorprothixene—Midazolam—Clobazam—epilepsy syndrome	0.00504	0.0181	CrCrCtD
Chlorprothixene—Flurazepam—Clobazam—epilepsy syndrome	0.00504	0.0181	CrCrCtD
Chlorprothixene—Triazolam—Diazepam—epilepsy syndrome	0.00498	0.0179	CrCrCtD
Chlorprothixene—Camazepam—Diazepam—epilepsy syndrome	0.00498	0.0179	CrCrCtD
Chlorprothixene—Adinazolam—Diazepam—epilepsy syndrome	0.00498	0.0179	CrCrCtD
Chlorprothixene—Temazepam—Midazolam—epilepsy syndrome	0.00496	0.0178	CrCrCtD
Chlorprothixene—ABCB1—Phenobarbital—epilepsy syndrome	0.00482	0.0957	CbGbCtD
Chlorprothixene—Fludiazepam—Clonazepam—epilepsy syndrome	0.00481	0.0173	CrCrCtD
Chlorprothixene—Temazepam—Clobazam—epilepsy syndrome	0.00476	0.0171	CrCrCtD
Chlorprothixene—ABCB1—Midazolam—epilepsy syndrome	0.00475	0.0944	CbGbCtD
Chlorprothixene—Amitriptyline—Oxcarbazepine—epilepsy syndrome	0.00471	0.0169	CrCrCtD
Chlorprothixene—Midazolam—Diazepam—epilepsy syndrome	0.00468	0.0168	CrCrCtD
Chlorprothixene—Flurazepam—Diazepam—epilepsy syndrome	0.00468	0.0168	CrCrCtD
Chlorprothixene—Fludiazepam—Midazolam—epilepsy syndrome	0.00459	0.0165	CrCrCtD
Chlorprothixene—Delorazepam—Clonazepam—epilepsy syndrome	0.00458	0.0165	CrCrCtD
Chlorprothixene—ABCB1—Diazepam—epilepsy syndrome	0.00457	0.0908	CbGbCtD
Chlorprothixene—Lorazepam—Diazepam—epilepsy syndrome	0.00455	0.0164	CrCrCtD
Chlorprothixene—Temazepam—Diazepam—epilepsy syndrome	0.00442	0.0159	CrCrCtD
Chlorprothixene—Fludiazepam—Clobazam—epilepsy syndrome	0.0044	0.0158	CrCrCtD
Chlorprothixene—Diazepam—Clonazepam—epilepsy syndrome	0.00438	0.0157	CrCrCtD
Chlorprothixene—Delorazepam—Midazolam—epilepsy syndrome	0.00437	0.0157	CrCrCtD
Chlorprothixene—Delorazepam—Clobazam—epilepsy syndrome	0.00419	0.0151	CrCrCtD
Chlorprothixene—Diazepam—Midazolam—epilepsy syndrome	0.00417	0.015	CrCrCtD
Chlorprothixene—Diazepam—Oxcarbazepine—epilepsy syndrome	0.00417	0.015	CrCrCtD
Chlorprothixene—Fludiazepam—Diazepam—epilepsy syndrome	0.00409	0.0147	CrCrCtD
Chlorprothixene—Diazepam—Clobazam—epilepsy syndrome	0.004	0.0144	CrCrCtD
Chlorprothixene—Clomipramine—Clobazam—epilepsy syndrome	0.004	0.0144	CrCrCtD
Chlorprothixene—Promethazine—Carbamazepine—epilepsy syndrome	0.00393	0.0141	CrCrCtD
Chlorprothixene—Delorazepam—Diazepam—epilepsy syndrome	0.00389	0.014	CrCrCtD
Chlorprothixene—Alimemazine—Carbamazepine—epilepsy syndrome	0.00386	0.0139	CrCrCtD
Chlorprothixene—Clomipramine—Diazepam—epilepsy syndrome	0.00372	0.0134	CrCrCtD
Chlorprothixene—Promethazine—Oxcarbazepine—epilepsy syndrome	0.00362	0.013	CrCrCtD
Chlorprothixene—Alimemazine—Oxcarbazepine—epilepsy syndrome	0.00356	0.0128	CrCrCtD
Chlorprothixene—Chlorpromazine—Clobazam—epilepsy syndrome	0.00354	0.0127	CrCrCtD
Chlorprothixene—Promazine—Carbamazepine—epilepsy syndrome	0.00333	0.012	CrCrCtD
Chlorprothixene—Prochlorperazine—Clobazam—epilepsy syndrome	0.00318	0.0114	CrCrCtD
Chlorprothixene—Promazine—Oxcarbazepine—epilepsy syndrome	0.00306	0.011	CrCrCtD
Chlorprothixene—HTR2A—phrenic nerve—epilepsy syndrome	0.00204	0.076	CbGeAlD
Chlorprothixene—DRD3—telencephalic ventricle—epilepsy syndrome	0.00155	0.0577	CbGeAlD
Chlorprothixene—DRD1—telencephalic ventricle—epilepsy syndrome	0.00111	0.0413	CbGeAlD
Chlorprothixene—HTR6—ganglion—epilepsy syndrome	0.000926	0.0346	CbGeAlD
Chlorprothixene—HTR2A—locus ceruleus—epilepsy syndrome	0.000909	0.034	CbGeAlD
Chlorprothixene—HTR2C—telencephalic ventricle—epilepsy syndrome	0.00086	0.0321	CbGeAlD
Chlorprothixene—HTR2A—cerebellar cortex—epilepsy syndrome	0.000741	0.0277	CbGeAlD
Chlorprothixene—HTR2A—vagus nerve—epilepsy syndrome	0.000696	0.026	CbGeAlD
Chlorprothixene—DRD1—ganglion—epilepsy syndrome	0.000689	0.0257	CbGeAlD
Chlorprothixene—DRD2—telencephalic ventricle—epilepsy syndrome	0.000654	0.0244	CbGeAlD
Chlorprothixene—HTR2C—ganglion—epilepsy syndrome	0.000535	0.02	CbGeAlD
Chlorprothixene—HTR2A—pons—epilepsy syndrome	0.000524	0.0196	CbGeAlD
Chlorprothixene—HTR2A—autonomic nervous system—epilepsy syndrome	0.000483	0.018	CbGeAlD
Chlorprothixene—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000431	0.0161	CbGeAlD
Chlorprothixene—DRD2—ganglion—epilepsy syndrome	0.000407	0.0152	CbGeAlD
Chlorprothixene—HTR6—forebrain—epilepsy syndrome	0.000388	0.0145	CbGeAlD
Chlorprothixene—HTR6—telencephalon—epilepsy syndrome	0.000357	0.0133	CbGeAlD
Chlorprothixene—DRD2—hindbrain—epilepsy syndrome	0.000309	0.0115	CbGeAlD
Chlorprothixene—DRD1—brainstem—epilepsy syndrome	0.000299	0.0112	CbGeAlD
Chlorprothixene—DRD1—forebrain—epilepsy syndrome	0.000289	0.0108	CbGeAlD
Chlorprothixene—HTR2A—ganglion—epilepsy syndrome	0.000268	0.01	CbGeAlD
Chlorprothixene—DRD1—telencephalon—epilepsy syndrome	0.000266	0.00992	CbGeAlD
Chlorprothixene—CHRM4—head—epilepsy syndrome	0.000249	0.00928	CbGeAlD
Chlorprothixene—CHRM4—nervous system—epilepsy syndrome	0.000236	0.0088	CbGeAlD
Chlorprothixene—CHRM2—forebrain—epilepsy syndrome	0.000233	0.0087	CbGeAlD
Chlorprothixene—HTR2C—brainstem—epilepsy syndrome	0.000233	0.00868	CbGeAlD
Chlorprothixene—DRD3—head—epilepsy syndrome	0.000231	0.00863	CbGeAlD
Chlorprothixene—CHRM4—central nervous system—epilepsy syndrome	0.000227	0.00847	CbGeAlD
Chlorprothixene—HTR2C—forebrain—epilepsy syndrome	0.000224	0.00838	CbGeAlD
Chlorprothixene—HTR6—head—epilepsy syndrome	0.000222	0.00831	CbGeAlD
Chlorprothixene—DRD3—nervous system—epilepsy syndrome	0.000219	0.00818	CbGeAlD
Chlorprothixene—CHRM2—telencephalon—epilepsy syndrome	0.000214	0.008	CbGeAlD
Chlorprothixene—CHRM1—forebrain—epilepsy syndrome	0.000212	0.00792	CbGeAlD
Chlorprothixene—DRD3—central nervous system—epilepsy syndrome	0.000211	0.00788	CbGeAlD
Chlorprothixene—HTR6—nervous system—epilepsy syndrome	0.000211	0.00787	CbGeAlD
Chlorprothixene—HTR2B—forebrain—epilepsy syndrome	0.000211	0.00787	CbGeAlD
Chlorprothixene—HTR2C—telencephalon—epilepsy syndrome	0.000206	0.00771	CbGeAlD
Chlorprothixene—HTR2A—hindbrain—epilepsy syndrome	0.000204	0.0076	CbGeAlD
Chlorprothixene—HTR6—central nervous system—epilepsy syndrome	0.000203	0.00758	CbGeAlD
Chlorprothixene—CHRM1—telencephalon—epilepsy syndrome	0.000195	0.00728	CbGeAlD
Chlorprothixene—CHRM5—head—epilepsy syndrome	0.000194	0.00725	CbGeAlD
Chlorprothixene—HTR2B—telencephalon—epilepsy syndrome	0.000194	0.00724	CbGeAlD
Chlorprothixene—DRD1—midbrain—epilepsy syndrome	0.000191	0.00713	CbGeAlD
Chlorprothixene—CHRM3—forebrain—epilepsy syndrome	0.00019	0.00708	CbGeAlD
Chlorprothixene—CHRM5—nervous system—epilepsy syndrome	0.000184	0.00688	CbGeAlD
Chlorprothixene—CHRM4—brain—epilepsy syndrome	0.00018	0.00673	CbGeAlD
Chlorprothixene—CHRM5—central nervous system—epilepsy syndrome	0.000177	0.00662	CbGeAlD
Chlorprothixene—DRD2—brainstem—epilepsy syndrome	0.000177	0.00661	CbGeAlD
Chlorprothixene—CHRM3—telencephalon—epilepsy syndrome	0.000174	0.00651	CbGeAlD
Chlorprothixene—DRD2—forebrain—epilepsy syndrome	0.000171	0.00637	CbGeAlD
Chlorprothixene—DRD3—brain—epilepsy syndrome	0.000167	0.00625	CbGeAlD
Chlorprothixene—DRD1—head—epilepsy syndrome	0.000165	0.00618	CbGeAlD
Chlorprothixene—HTR2C—medulla oblongata—epilepsy syndrome	0.000162	0.00606	CbGeAlD
Chlorprothixene—HTR6—brain—epilepsy syndrome	0.000161	0.00602	CbGeAlD
Chlorprothixene—DRD2—telencephalon—epilepsy syndrome	0.000157	0.00586	CbGeAlD
Chlorprothixene—DRD1—nervous system—epilepsy syndrome	0.000157	0.00586	CbGeAlD
Chlorprothixene—DRD1—central nervous system—epilepsy syndrome	0.000151	0.00564	CbGeAlD
Chlorprothixene—HTR2C—midbrain—epilepsy syndrome	0.000148	0.00553	CbGeAlD
Chlorprothixene—HTR2C—spinal cord—epilepsy syndrome	0.000145	0.0054	CbGeAlD
Chlorprothixene—CHRM5—brain—epilepsy syndrome	0.000141	0.00526	CbGeAlD
Chlorprothixene—HRH1—forebrain—epilepsy syndrome	0.000135	0.00503	CbGeAlD
Chlorprothixene—CHRM2—head—epilepsy syndrome	0.000133	0.00498	CbGeAlD
Chlorprothixene—HTR2C—head—epilepsy syndrome	0.000129	0.0048	CbGeAlD
Chlorprothixene—CHRM2—nervous system—epilepsy syndrome	0.000126	0.00472	CbGeAlD
Chlorprothixene—HRH1—telencephalon—epilepsy syndrome	0.000124	0.00463	CbGeAlD
Chlorprothixene—HTR2C—nervous system—epilepsy syndrome	0.000122	0.00455	CbGeAlD
Chlorprothixene—CHRM2—central nervous system—epilepsy syndrome	0.000122	0.00455	CbGeAlD
Chlorprothixene—CHRM1—head—epilepsy syndrome	0.000121	0.00453	CbGeAlD
Chlorprothixene—HTR2B—head—epilepsy syndrome	0.000121	0.00451	CbGeAlD
Chlorprothixene—DRD1—brain—epilepsy syndrome	0.00012	0.00448	CbGeAlD
Chlorprothixene—HTR2C—central nervous system—epilepsy syndrome	0.000117	0.00438	CbGeAlD
Chlorprothixene—HTR2A—brainstem—epilepsy syndrome	0.000117	0.00436	CbGeAlD
Chlorprothixene—CHRM1—nervous system—epilepsy syndrome	0.000115	0.0043	CbGeAlD
Chlorprothixene—HTR2B—nervous system—epilepsy syndrome	0.000114	0.00427	CbGeAlD
Chlorprothixene—DRD2—midbrain—epilepsy syndrome	0.000113	0.00421	CbGeAlD
Chlorprothixene—HTR2A—forebrain—epilepsy syndrome	0.000113	0.0042	CbGeAlD
Chlorprothixene—CHRM1—central nervous system—epilepsy syndrome	0.000111	0.00414	CbGeAlD
Chlorprothixene—HTR2B—central nervous system—epilepsy syndrome	0.00011	0.00412	CbGeAlD
Chlorprothixene—CHRM3—head—epilepsy syndrome	0.000109	0.00406	CbGeAlD
Chlorprothixene—HTR2A—telencephalon—epilepsy syndrome	0.000104	0.00387	CbGeAlD
Chlorprothixene—CHRM3—nervous system—epilepsy syndrome	0.000103	0.00385	CbGeAlD
Chlorprothixene—Olopatadine—S100B—epilepsy syndrome	0.0001	0.0374	CrCbGaD
Chlorprothixene—CHRM3—central nervous system—epilepsy syndrome	9.92e-05	0.0037	CbGeAlD
Chlorprothixene—DRD2—head—epilepsy syndrome	9.78e-05	0.00365	CbGeAlD
Chlorprothixene—CHRM2—brain—epilepsy syndrome	9.66e-05	0.00361	CbGeAlD
Chlorprothixene—HTR2C—brain—epilepsy syndrome	9.31e-05	0.00348	CbGeAlD
Chlorprothixene—DRD2—nervous system—epilepsy syndrome	9.27e-05	0.00346	CbGeAlD
Chlorprothixene—DRD2—central nervous system—epilepsy syndrome	8.92e-05	0.00333	CbGeAlD
Chlorprothixene—CHRM1—brain—epilepsy syndrome	8.8e-05	0.00328	CbGeAlD
Chlorprothixene—HTR2B—brain—epilepsy syndrome	8.75e-05	0.00327	CbGeAlD
Chlorprothixene—DRD2—cerebellum—epilepsy syndrome	8.72e-05	0.00326	CbGeAlD
Chlorprothixene—HTR2A—medulla oblongata—epilepsy syndrome	8.14e-05	0.00304	CbGeAlD
Chlorprothixene—CHRM3—brain—epilepsy syndrome	7.87e-05	0.00294	CbGeAlD
Chlorprothixene—HRH1—head—epilepsy syndrome	7.72e-05	0.00288	CbGeAlD
Chlorprothixene—HTR2A—midbrain—epilepsy syndrome	7.44e-05	0.00278	CbGeAlD
Chlorprothixene—ABCB1—forebrain—epilepsy syndrome	7.38e-05	0.00276	CbGeAlD
Chlorprothixene—HRH1—nervous system—epilepsy syndrome	7.32e-05	0.00273	CbGeAlD
Chlorprothixene—HTR2A—spinal cord—epilepsy syndrome	7.26e-05	0.00271	CbGeAlD
Chlorprothixene—DRD2—brain—epilepsy syndrome	7.08e-05	0.00265	CbGeAlD
Chlorprothixene—HRH1—central nervous system—epilepsy syndrome	7.05e-05	0.00263	CbGeAlD
Chlorprothixene—ABCB1—telencephalon—epilepsy syndrome	6.79e-05	0.00253	CbGeAlD
Chlorprothixene—HTR2A—head—epilepsy syndrome	6.45e-05	0.00241	CbGeAlD
Chlorprothixene—HTR2A—nervous system—epilepsy syndrome	6.11e-05	0.00228	CbGeAlD
Chlorprothixene—HTR2A—central nervous system—epilepsy syndrome	5.89e-05	0.0022	CbGeAlD
Chlorprothixene—HTR2A—cerebellum—epilepsy syndrome	5.75e-05	0.00215	CbGeAlD
Chlorprothixene—HRH1—brain—epilepsy syndrome	5.59e-05	0.00209	CbGeAlD
Chlorprothixene—ABCB1—medulla oblongata—epilepsy syndrome	5.33e-05	0.00199	CbGeAlD
Chlorprothixene—ABCB1—midbrain—epilepsy syndrome	4.87e-05	0.00182	CbGeAlD
Chlorprothixene—ABCB1—spinal cord—epilepsy syndrome	4.75e-05	0.00178	CbGeAlD
Chlorprothixene—HTR2A—brain—epilepsy syndrome	4.67e-05	0.00174	CbGeAlD
Chlorprothixene—Lorazepam—GABRG2—epilepsy syndrome	4.57e-05	0.017	CrCbGaD
Chlorprothixene—Amitriptyline—KCND2—epilepsy syndrome	4.53e-05	0.0169	CrCbGaD
Chlorprothixene—Cinolazepam—GABRD—epilepsy syndrome	4.33e-05	0.0161	CrCbGaD
Chlorprothixene—ABCB1—head—epilepsy syndrome	4.23e-05	0.00158	CbGeAlD
Chlorprothixene—Amitriptyline—KCNQ2—epilepsy syndrome	4.21e-05	0.0157	CrCbGaD
Chlorprothixene—Amitriptyline—KCNQ3—epilepsy syndrome	4.21e-05	0.0157	CrCbGaD
Chlorprothixene—ABCB1—nervous system—epilepsy syndrome	4.01e-05	0.0015	CbGeAlD
Chlorprothixene—Chlordiazepoxide—GABRG2—epilepsy syndrome	3.98e-05	0.0148	CrCbGaD
Chlorprothixene—ABCB1—central nervous system—epilepsy syndrome	3.86e-05	0.00144	CbGeAlD
Chlorprothixene—ABCB1—cerebellum—epilepsy syndrome	3.77e-05	0.00141	CbGeAlD
Chlorprothixene—Lorazepam—GABRB3—epilepsy syndrome	3.68e-05	0.0137	CrCbGaD
Chlorprothixene—Adinazolam—GABRD—epilepsy syndrome	3.62e-05	0.0135	CrCbGaD
Chlorprothixene—Fludiazepam—GABRD—epilepsy syndrome	3.59e-05	0.0134	CrCbGaD
Chlorprothixene—Amitriptyline—NTRK2—epilepsy syndrome	3.58e-05	0.0134	CrCbGaD
Chlorprothixene—Cinolazepam—GABRG2—epilepsy syndrome	3.28e-05	0.0122	CrCbGaD
Chlorprothixene—Flurazepam—GABRD—epilepsy syndrome	3.27e-05	0.0122	CrCbGaD
Chlorprothixene—Triazolam—GABRD—epilepsy syndrome	3.26e-05	0.0122	CrCbGaD
Chlorprothixene—Chlordiazepoxide—GABRB3—epilepsy syndrome	3.2e-05	0.0119	CrCbGaD
Chlorprothixene—Chlordiazepoxide—GABRA5—epilepsy syndrome	3.2e-05	0.0119	CrCbGaD
Chlorprothixene—Lorazepam—GABRA1—epilepsy syndrome	3.16e-05	0.0118	CrCbGaD
Chlorprothixene—Temazepam—GABRD—epilepsy syndrome	3.12e-05	0.0116	CrCbGaD
Chlorprothixene—ABCB1—brain—epilepsy syndrome	3.06e-05	0.00114	CbGeAlD
Chlorprothixene—Midazolam—GABRD—epilepsy syndrome	3.03e-05	0.0113	CrCbGaD
Chlorprothixene—Dimetindene—CHRM2—epilepsy syndrome	2.95e-05	0.011	CrCbGaD
Chlorprothixene—Cyamemazine—CHRM2—epilepsy syndrome	2.87e-05	0.0107	CrCbGaD
Chlorprothixene—Chlordiazepoxide—GABRB2—epilepsy syndrome	2.8e-05	0.0104	CrCbGaD
Chlorprothixene—Chlordiazepoxide—GABRA1—epilepsy syndrome	2.75e-05	0.0102	CrCbGaD
Chlorprothixene—Adinazolam—GABRG2—epilepsy syndrome	2.74e-05	0.0102	CrCbGaD
Chlorprothixene—Fludiazepam—GABRG2—epilepsy syndrome	2.72e-05	0.0101	CrCbGaD
Chlorprothixene—Cinolazepam—GABRB3—epilepsy syndrome	2.64e-05	0.00984	CrCbGaD
Chlorprothixene—Cinolazepam—GABRA5—epilepsy syndrome	2.64e-05	0.00984	CrCbGaD
Chlorprothixene—Diazepam—GABRD—epilepsy syndrome	2.59e-05	0.00967	CrCbGaD
Chlorprothixene—Flurazepam—GABRG2—epilepsy syndrome	2.47e-05	0.00922	CrCbGaD
Chlorprothixene—Triazolam—GABRG2—epilepsy syndrome	2.47e-05	0.00921	CrCbGaD
Chlorprothixene—Triflupromazine—CHRM1—epilepsy syndrome	2.44e-05	0.00909	CrCbGaD
Chlorprothixene—Temazepam—GABRG2—epilepsy syndrome	2.37e-05	0.00882	CrCbGaD
Chlorprothixene—Cinolazepam—GABRB2—epilepsy syndrome	2.31e-05	0.00862	CrCbGaD
Chlorprothixene—Midazolam—GABRG2—epilepsy syndrome	2.29e-05	0.00855	CrCbGaD
Chlorprothixene—Cinolazepam—GABRA1—epilepsy syndrome	2.27e-05	0.00845	CrCbGaD
Chlorprothixene—Adinazolam—GABRA5—epilepsy syndrome	2.21e-05	0.00824	CrCbGaD
Chlorprothixene—Adinazolam—GABRB3—epilepsy syndrome	2.21e-05	0.00824	CrCbGaD
Chlorprothixene—Fludiazepam—GABRB3—epilepsy syndrome	2.19e-05	0.00816	CrCbGaD
Chlorprothixene—Fludiazepam—GABRA5—epilepsy syndrome	2.19e-05	0.00816	CrCbGaD
Chlorprothixene—Flurazepam—GABRA5—epilepsy syndrome	1.99e-05	0.00742	CrCbGaD
Chlorprothixene—Flurazepam—GABRB3—epilepsy syndrome	1.99e-05	0.00742	CrCbGaD
Chlorprothixene—Triflupromazine—CHRM2—epilepsy syndrome	1.99e-05	0.00742	CrCbGaD
Chlorprothixene—Triazolam—GABRA5—epilepsy syndrome	1.99e-05	0.00741	CrCbGaD
Chlorprothixene—Triazolam—GABRB3—epilepsy syndrome	1.99e-05	0.00741	CrCbGaD
Chlorprothixene—Diazepam—GABRG2—epilepsy syndrome	1.97e-05	0.00733	CrCbGaD
Chlorprothixene—Propiomazine—CHRM3—epilepsy syndrome	1.93e-05	0.00721	CrCbGaD
Chlorprothixene—Adinazolam—GABRB2—epilepsy syndrome	1.93e-05	0.00721	CrCbGaD
Chlorprothixene—Fludiazepam—GABRB2—epilepsy syndrome	1.92e-05	0.00714	CrCbGaD
Chlorprothixene—Temazepam—GABRB3—epilepsy syndrome	1.9e-05	0.0071	CrCbGaD
Chlorprothixene—Temazepam—GABRA5—epilepsy syndrome	1.9e-05	0.0071	CrCbGaD
Chlorprothixene—Adinazolam—GABRA1—epilepsy syndrome	1.9e-05	0.00707	CrCbGaD
Chlorprothixene—Fludiazepam—GABRA1—epilepsy syndrome	1.88e-05	0.007	CrCbGaD
Chlorprothixene—Midazolam—GABRB3—epilepsy syndrome	1.85e-05	0.00688	CrCbGaD
Chlorprothixene—Midazolam—GABRA5—epilepsy syndrome	1.85e-05	0.00688	CrCbGaD
Chlorprothixene—Propiomazine—CHRM1—epilepsy syndrome	1.8e-05	0.00672	CrCbGaD
Chlorprothixene—Nortriptyline—CHRM3—epilepsy syndrome	1.8e-05	0.0067	CrCbGaD
Chlorprothixene—Zuclopenthixol—ADRA2A—epilepsy syndrome	1.75e-05	0.00654	CrCbGaD
Chlorprothixene—Flurazepam—GABRB2—epilepsy syndrome	1.74e-05	0.0065	CrCbGaD
Chlorprothixene—Triazolam—GABRB2—epilepsy syndrome	1.74e-05	0.00649	CrCbGaD
Chlorprothixene—Flurazepam—GABRA1—epilepsy syndrome	1.71e-05	0.00637	CrCbGaD
Chlorprothixene—Triazolam—GABRA1—epilepsy syndrome	1.71e-05	0.00636	CrCbGaD
Chlorprothixene—Prochlorperazine—CHRM2—epilepsy syndrome	1.69e-05	0.00631	CrCbGaD
Chlorprothixene—Nortriptyline—CHRM1—epilepsy syndrome	1.68e-05	0.00625	CrCbGaD
Chlorprothixene—Temazepam—GABRB2—epilepsy syndrome	1.67e-05	0.00621	CrCbGaD
Chlorprothixene—Triflupromazine—BCHE—epilepsy syndrome	1.66e-05	0.00619	CrCbGaD
Chlorprothixene—Methotrimeprazine—CHRM3—epilepsy syndrome	1.65e-05	0.00616	CrCbGaD
Chlorprothixene—Temazepam—GABRA1—epilepsy syndrome	1.63e-05	0.00609	CrCbGaD
Chlorprothixene—Promethazine—CHRM3—epilepsy syndrome	1.63e-05	0.00607	CrCbGaD
Chlorprothixene—Midazolam—GABRB2—epilepsy syndrome	1.62e-05	0.00602	CrCbGaD
Chlorprothixene—Doxepin—CHRM3—epilepsy syndrome	1.61e-05	0.00601	CrCbGaD
Chlorprothixene—Midazolam—GABRA1—epilepsy syndrome	1.59e-05	0.00591	CrCbGaD
Chlorprothixene—Diazepam—GABRB3—epilepsy syndrome	1.58e-05	0.0059	CrCbGaD
Chlorprothixene—Diazepam—GABRA5—epilepsy syndrome	1.58e-05	0.0059	CrCbGaD
Chlorprothixene—Methotrimeprazine—CHRM1—epilepsy syndrome	1.54e-05	0.00575	CrCbGaD
Chlorprothixene—Promethazine—CHRM1—epilepsy syndrome	1.52e-05	0.00566	CrCbGaD
Chlorprothixene—Thiothixene—ADRA2A—epilepsy syndrome	1.51e-05	0.00564	CrCbGaD
Chlorprothixene—Doxepin—CHRM1—epilepsy syndrome	1.5e-05	0.00561	CrCbGaD
Chlorprothixene—Propiomazine—CHRM2—epilepsy syndrome	1.47e-05	0.00549	CrCbGaD
Chlorprothixene—Amitriptyline—OPRD1—epilepsy syndrome	1.47e-05	0.00547	CrCbGaD
Chlorprothixene—Cyamemazine—HTR2A—epilepsy syndrome	1.43e-05	0.00535	CrCbGaD
Chlorprothixene—Promazine—CHRM3—epilepsy syndrome	1.43e-05	0.00534	CrCbGaD
Chlorprothixene—Diazepam—GABRB2—epilepsy syndrome	1.39e-05	0.00516	CrCbGaD
Chlorprothixene—Nortriptyline—CHRM2—epilepsy syndrome	1.37e-05	0.0051	CrCbGaD
Chlorprothixene—Diazepam—GABRA1—epilepsy syndrome	1.36e-05	0.00506	CrCbGaD
Chlorprothixene—Carbinoxamine—CYP2C19—epilepsy syndrome	1.35e-05	0.00504	CrCbGaD
Chlorprothixene—Promazine—CHRM1—epilepsy syndrome	1.34e-05	0.00498	CrCbGaD
Chlorprothixene—Cyclobenzaprine—HTR2A—epilepsy syndrome	1.33e-05	0.00497	CrCbGaD
Chlorprothixene—Chlorpromazine—CHRM3—epilepsy syndrome	1.26e-05	0.0047	CrCbGaD
Chlorprothixene—Methotrimeprazine—CHRM2—epilepsy syndrome	1.26e-05	0.00469	CrCbGaD
Chlorprothixene—Amitriptyline—CHRM3—epilepsy syndrome	1.25e-05	0.00465	CrCbGaD
Chlorprothixene—Promethazine—CHRM2—epilepsy syndrome	1.24e-05	0.00462	CrCbGaD
Chlorprothixene—Doxepin—CHRM2—epilepsy syndrome	1.23e-05	0.00458	CrCbGaD
Chlorprothixene—Cyclobenzaprine—CYP2D6—epilepsy syndrome	1.22e-05	0.00455	CrCbGaD
Chlorprothixene—Chlorphenamine—SLC6A4—epilepsy syndrome	1.21e-05	0.00452	CrCbGaD
Chlorprothixene—Perphenazine—HTR7—epilepsy syndrome	1.2e-05	0.00449	CrCbGaD
Chlorprothixene—Clomipramine—ADRA2A—epilepsy syndrome	1.2e-05	0.00445	CrCbGaD
Chlorprothixene—Chlorpromazine—CHRM1—epilepsy syndrome	1.18e-05	0.00438	CrCbGaD
Chlorprothixene—Amitriptyline—CHRM1—epilepsy syndrome	1.16e-05	0.00433	CrCbGaD
Chlorprothixene—Amitriptyline—OPRM1—epilepsy syndrome	1.12e-05	0.00418	CrCbGaD
Chlorprothixene—Promazine—CHRM2—epilepsy syndrome	1.09e-05	0.00407	CrCbGaD
Chlorprothixene—Methotrimeprazine—ADRA2A—epilepsy syndrome	1.07e-05	0.00401	CrCbGaD
Chlorprothixene—Doxepin—ADRA2A—epilepsy syndrome	1.05e-05	0.00391	CrCbGaD
Chlorprothixene—Perphenazine—ADRA2A—epilepsy syndrome	1.03e-05	0.00385	CrCbGaD
Chlorprothixene—Zuclopenthixol—HTR2A—epilepsy syndrome	1.03e-05	0.00383	CrCbGaD
Chlorprothixene—Carbinoxamine—CYP2D6—epilepsy syndrome	1e-05	0.00374	CrCbGaD
Chlorprothixene—Chlorpromazine—CHRM2—epilepsy syndrome	9.61e-06	0.00358	CrCbGaD
Chlorprothixene—Chlordiazepoxide—CYP2D6—epilepsy syndrome	9.57e-06	0.00357	CrCbGaD
Chlorprothixene—Chlorpromazine—HTR7—epilepsy syndrome	9.56e-06	0.00356	CrCbGaD
Chlorprothixene—Amitriptyline—CHRM2—epilepsy syndrome	9.5e-06	0.00354	CrCbGaD
Chlorprothixene—Amitriptyline—HTR7—epilepsy syndrome	9.45e-06	0.00352	CrCbGaD
Chlorprothixene—Zuclopenthixol—CYP2D6—epilepsy syndrome	9.4e-06	0.0035	CrCbGaD
Chlorprothixene—Promazine—ADRA2A—epilepsy syndrome	9.32e-06	0.00347	CrCbGaD
Chlorprothixene—Acepromazine—HTR2A—epilepsy syndrome	9.22e-06	0.00344	CrCbGaD
Chlorprothixene—Clomipramine—SLC6A4—epilepsy syndrome	9.12e-06	0.0034	CrCbGaD
Chlorprothixene—Adinazolam—CYP2C19—epilepsy syndrome	8.91e-06	0.00332	CrCbGaD
Chlorprothixene—Nortriptyline—SLC6A4—epilepsy syndrome	8.91e-06	0.00332	CrCbGaD
Chlorprothixene—Thiothixene—HTR2A—epilepsy syndrome	8.86e-06	0.0033	CrCbGaD
Chlorprothixene—Clomipramine—CYP2C19—epilepsy syndrome	8.64e-06	0.00322	CrCbGaD
Chlorprothixene—Chlorphenamine—CYP2D6—epilepsy syndrome	8.53e-06	0.00318	CrCbGaD
Chlorprothixene—Nortriptyline—CYP2C19—epilepsy syndrome	8.45e-06	0.00315	CrCbGaD
Chlorprothixene—Chlorpromazine—ADRA2A—epilepsy syndrome	8.2e-06	0.00306	CrCbGaD
Chlorprothixene—Thiothixene—CYP2D6—epilepsy syndrome	8.11e-06	0.00302	CrCbGaD
Chlorprothixene—Amitriptyline—ADRA2A—epilepsy syndrome	8.11e-06	0.00302	CrCbGaD
Chlorprothixene—Chlorpromazine—BCHE—epilepsy syndrome	8.01e-06	0.00299	CrCbGaD
Chlorprothixene—Doxepin—SLC6A4—epilepsy syndrome	8e-06	0.00298	CrCbGaD
Chlorprothixene—Prochlorperazine—CYP2D6—epilepsy syndrome	7.75e-06	0.00289	CrCbGaD
Chlorprothixene—Temazepam—CYP2C19—epilepsy syndrome	7.68e-06	0.00286	CrCbGaD
Chlorprothixene—Doxepin—CYP2C19—epilepsy syndrome	7.58e-06	0.00282	CrCbGaD
Chlorprothixene—Perphenazine—CYP2C19—epilepsy syndrome	7.47e-06	0.00279	CrCbGaD
Chlorprothixene—Propiomazine—HTR2A—epilepsy syndrome	7.37e-06	0.00275	CrCbGaD
Chlorprothixene—Clomipramine—HTR2A—epilepsy syndrome	7.01e-06	0.00261	CrCbGaD
Chlorprothixene—Nortriptyline—HTR2A—epilepsy syndrome	6.85e-06	0.00255	CrCbGaD
Chlorprothixene—Promazine—CYP2C19—epilepsy syndrome	6.74e-06	0.00251	CrCbGaD
Chlorprothixene—Triflupromazine—ABCB1—epilepsy syndrome	6.51e-06	0.00242	CrCbGaD
Chlorprothixene—Clomipramine—CYP2D6—epilepsy syndrome	6.41e-06	0.00239	CrCbGaD
Chlorprothixene—Diazepam—CYP2C19—epilepsy syndrome	6.38e-06	0.00238	CrCbGaD
Chlorprothixene—Acepromazine—ALB—epilepsy syndrome	6.31e-06	0.00235	CrCbGaD
Chlorprothixene—Methotrimeprazine—HTR2A—epilepsy syndrome	6.3e-06	0.00235	CrCbGaD
Chlorprothixene—Nortriptyline—CYP2D6—epilepsy syndrome	6.26e-06	0.00233	CrCbGaD
Chlorprothixene—Promethazine—HTR2A—epilepsy syndrome	6.21e-06	0.00231	CrCbGaD
Chlorprothixene—Amitriptyline—SLC6A4—epilepsy syndrome	6.18e-06	0.0023	CrCbGaD
Chlorprothixene—Doxepin—HTR2A—epilepsy syndrome	6.14e-06	0.00229	CrCbGaD
Chlorprothixene—Thiothixene—ALB—epilepsy syndrome	6.07e-06	0.00226	CrCbGaD
Chlorprothixene—Perphenazine—HTR2A—epilepsy syndrome	6.06e-06	0.00226	CrCbGaD
Chlorprothixene—Amitriptyline—CYP2C19—epilepsy syndrome	5.86e-06	0.00218	CrCbGaD
Chlorprothixene—Methotrimeprazine—CYP2D6—epilepsy syndrome	5.76e-06	0.00215	CrCbGaD
Chlorprothixene—Promethazine—CYP2D6—epilepsy syndrome	5.68e-06	0.00212	CrCbGaD
Chlorprothixene—Doxepin—CYP2D6—epilepsy syndrome	5.62e-06	0.00209	CrCbGaD
Chlorprothixene—Perphenazine—CYP2D6—epilepsy syndrome	5.54e-06	0.00206	CrCbGaD
Chlorprothixene—Promazine—HTR2A—epilepsy syndrome	5.46e-06	0.00204	CrCbGaD
Chlorprothixene—Chlorpromazine—HTR2A—epilepsy syndrome	4.81e-06	0.00179	CrCbGaD
Chlorprothixene—Clomipramine—ALB—epilepsy syndrome	4.79e-06	0.00179	CrCbGaD
Chlorprothixene—Amitriptyline—HTR2A—epilepsy syndrome	4.75e-06	0.00177	CrCbGaD
Chlorprothixene—Nortriptyline—ALB—epilepsy syndrome	4.69e-06	0.00175	CrCbGaD
Chlorprothixene—Clomipramine—ABCB1—epilepsy syndrome	4.58e-06	0.00171	CrCbGaD
Chlorprothixene—Chlorpromazine—CYP2D6—epilepsy syndrome	4.4e-06	0.00164	CrCbGaD
Chlorprothixene—Amitriptyline—CYP2D6—epilepsy syndrome	4.35e-06	0.00162	CrCbGaD
Chlorprothixene—Flurazepam—ABCB1—epilepsy syndrome	4.25e-06	0.00159	CrCbGaD
Chlorprothixene—Promethazine—ABCB1—epilepsy syndrome	4.05e-06	0.00151	CrCbGaD
Chlorprothixene—Doxepin—ABCB1—epilepsy syndrome	4.01e-06	0.0015	CrCbGaD
Chlorprothixene—Midazolam—ABCB1—epilepsy syndrome	3.94e-06	0.00147	CrCbGaD
Chlorprothixene—Diazepam—ALB—epilepsy syndrome	3.54e-06	0.00132	CrCbGaD
Chlorprothixene—Diazepam—ABCB1—epilepsy syndrome	3.38e-06	0.00126	CrCbGaD
Chlorprothixene—Chlorpromazine—ALB—epilepsy syndrome	3.29e-06	0.00123	CrCbGaD
Chlorprothixene—Amitriptyline—ALB—epilepsy syndrome	3.25e-06	0.00121	CrCbGaD
Chlorprothixene—Chlorpromazine—ABCB1—epilepsy syndrome	3.14e-06	0.00117	CrCbGaD
Chlorprothixene—Amitriptyline—ABCB1—epilepsy syndrome	3.1e-06	0.00116	CrCbGaD
Chlorprothixene—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	1.09e-06	2.07e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.08e-06	2.07e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	1.08e-06	2.07e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	1.08e-06	2.07e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	1.08e-06	2.06e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—TSC2—epilepsy syndrome	1.08e-06	2.06e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	1.08e-06	2.06e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—TH—epilepsy syndrome	1.08e-06	2.06e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—AGT—epilepsy syndrome	1.08e-06	2.06e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	1.08e-06	2.06e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	1.08e-06	2.05e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	1.07e-06	2.05e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	1.07e-06	2.04e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.07e-06	2.04e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	1.07e-06	2.03e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—POMC—epilepsy syndrome	1.06e-06	2.03e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—APOE—epilepsy syndrome	1.06e-06	2.02e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—NGF—epilepsy syndrome	1.06e-06	2.01e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.05e-06	2e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—POMC—epilepsy syndrome	1.05e-06	2e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.05e-06	2e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.04e-06	1.99e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	1.04e-06	1.99e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—CCL2—epilepsy syndrome	1.04e-06	1.98e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	1.04e-06	1.98e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—KDR—epilepsy syndrome	1.04e-06	1.98e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—NGF—epilepsy syndrome	1.04e-06	1.98e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	1.03e-06	1.97e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.03e-06	1.97e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—FGF2—epilepsy syndrome	1.03e-06	1.96e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	1.03e-06	1.96e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	1.03e-06	1.96e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—CCL2—epilepsy syndrome	1.03e-06	1.96e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	1.02e-06	1.94e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—RELA—epilepsy syndrome	1.01e-06	1.93e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	1.01e-06	1.93e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	1.01e-06	1.92e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	1e-06	1.92e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	1e-06	1.92e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	1e-06	1.91e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	9.98e-07	1.9e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	9.97e-07	1.9e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	9.94e-07	1.9e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—MTOR—epilepsy syndrome	9.94e-07	1.89e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	9.92e-07	1.89e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	9.87e-07	1.88e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—FGF2—epilepsy syndrome	9.86e-07	1.88e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	9.83e-07	1.87e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	9.8e-07	1.87e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	9.71e-07	1.85e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—RELA—epilepsy syndrome	9.56e-07	1.82e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	9.55e-07	1.82e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—AGT—epilepsy syndrome	9.53e-07	1.82e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—FGF2—epilepsy syndrome	9.4e-07	1.79e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	9.39e-07	1.79e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	9.38e-07	1.79e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—MTOR—epilepsy syndrome	9.38e-07	1.79e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	9.37e-07	1.79e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—POMC—epilepsy syndrome	9.36e-07	1.79e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—AGT—epilepsy syndrome	9.36e-07	1.78e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	9.34e-07	1.78e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—APOE—epilepsy syndrome	9.34e-07	1.78e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	9.33e-07	1.78e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	9.31e-07	1.78e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	9.3e-07	1.77e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—FGF2—epilepsy syndrome	9.27e-07	1.77e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	9.25e-07	1.76e-05	CbGpPWpGaD
Chlorprothixene—HTR6—GPCR downstream signaling—AKT1—epilepsy syndrome	9.23e-07	1.76e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	9.22e-07	1.76e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	9.21e-07	1.76e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	9.19e-07	1.75e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—APOE—epilepsy syndrome	9.17e-07	1.75e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—RELA—epilepsy syndrome	9.16e-07	1.75e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—KDR—epilepsy syndrome	9.15e-07	1.74e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	9.14e-07	1.74e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—CASP3—epilepsy syndrome	9.14e-07	1.74e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	9.11e-07	1.74e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	9.09e-07	1.73e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	9.07e-07	1.73e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	9.02e-07	1.72e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—HMOX1—epilepsy syndrome	9.02e-07	1.72e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	9.01e-07	1.72e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—KDR—epilepsy syndrome	8.99e-07	1.71e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—MTOR—epilepsy syndrome	8.98e-07	1.71e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	8.96e-07	1.71e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	8.93e-07	1.7e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—CAT—epilepsy syndrome	8.9e-07	1.7e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	8.9e-07	1.7e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—JUN—epilepsy syndrome	8.88e-07	1.69e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	8.84e-07	1.69e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	8.81e-07	1.68e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	8.77e-07	1.67e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—RELA—epilepsy syndrome	8.73e-07	1.66e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—GPCR downstream signaling—AKT1—epilepsy syndrome	8.7e-07	1.66e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	8.67e-07	1.65e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	8.65e-07	1.65e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—MMP9—epilepsy syndrome	8.64e-07	1.65e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	8.63e-07	1.65e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—CASP3—epilepsy syndrome	8.62e-07	1.64e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	8.62e-07	1.64e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	8.61e-07	1.64e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—RELA—epilepsy syndrome	8.61e-07	1.64e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	8.59e-07	1.64e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	8.59e-07	1.64e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	8.56e-07	1.63e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—MTOR—epilepsy syndrome	8.56e-07	1.63e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—ALB—epilepsy syndrome	8.54e-07	1.63e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	8.51e-07	1.62e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	8.48e-07	1.62e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—MTOR—epilepsy syndrome	8.44e-07	1.61e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	8.42e-07	1.61e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling by GPCR—AKT1—epilepsy syndrome	8.38e-07	1.6e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—JUN—epilepsy syndrome	8.38e-07	1.6e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	8.35e-07	1.59e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—GPCR downstream signaling—AKT1—epilepsy syndrome	8.34e-07	1.59e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—CASP3—epilepsy syndrome	8.26e-07	1.57e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—MMP9—epilepsy syndrome	8.15e-07	1.55e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	8.11e-07	1.55e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—GPX1—epilepsy syndrome	8.05e-07	1.53e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	8.04e-07	1.53e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—POMC—epilepsy syndrome	8.03e-07	1.53e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—JUN—epilepsy syndrome	8.02e-07	1.53e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—SRC—epilepsy syndrome	7.97e-07	1.52e-05	CbGpPWpGaD
Chlorprothixene—DRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	7.94e-07	1.51e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling by GPCR—AKT1—epilepsy syndrome	7.9e-07	1.51e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	7.9e-07	1.51e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	7.89e-07	1.5e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—POMC—epilepsy syndrome	7.88e-07	1.5e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	7.87e-07	1.5e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	7.85e-07	1.5e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	7.85e-07	1.5e-05	CbGpPWpGaD
Chlorprothixene—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	7.84e-07	1.49e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	7.83e-07	1.49e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	7.8e-07	1.49e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	7.76e-07	1.48e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	7.76e-07	1.48e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	7.75e-07	1.48e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	7.73e-07	1.47e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	7.71e-07	1.47e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	7.68e-07	1.47e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	7.66e-07	1.46e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	7.65e-07	1.46e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—JUN—epilepsy syndrome	7.64e-07	1.46e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	7.59e-07	1.45e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	7.57e-07	1.44e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—JUN—epilepsy syndrome	7.54e-07	1.44e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—SRC—epilepsy syndrome	7.51e-07	1.43e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—PTGS2—epilepsy syndrome	7.47e-07	1.42e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	7.46e-07	1.42e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	7.44e-07	1.42e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	7.34e-07	1.4e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	7.32e-07	1.4e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—VEGFA—epilepsy syndrome	7.32e-07	1.4e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	7.27e-07	1.39e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	7.21e-07	1.38e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	7.2e-07	1.37e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	7.12e-07	1.36e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	7.1e-07	1.35e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	7.08e-07	1.35e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—AGT—epilepsy syndrome	7.06e-07	1.35e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	7.01e-07	1.34e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	6.98e-07	1.33e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	6.97e-07	1.33e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	6.95e-07	1.32e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	6.92e-07	1.32e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—APOE—epilepsy syndrome	6.92e-07	1.32e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—SRC—epilepsy syndrome	6.86e-07	1.31e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	6.86e-07	1.31e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	6.8e-07	1.3e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—SRC—epilepsy syndrome	6.77e-07	1.29e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	6.73e-07	1.28e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	6.68e-07	1.27e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	6.59e-07	1.26e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—RELA—epilepsy syndrome	6.59e-07	1.26e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	6.54e-07	1.25e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	6.48e-07	1.24e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—RELA—epilepsy syndrome	6.47e-07	1.23e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	6.46e-07	1.23e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	6.45e-07	1.23e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	6.43e-07	1.23e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	6.36e-07	1.21e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	6.36e-07	1.21e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	6.36e-07	1.21e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	6.34e-07	1.21e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	6.32e-07	1.21e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	6.3e-07	1.2e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	6.24e-07	1.19e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	6.17e-07	1.18e-05	CbGpPWpGaD
Chlorprothixene—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	6e-07	1.14e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	5.94e-07	1.13e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—POMC—epilepsy syndrome	5.94e-07	1.13e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	5.9e-07	1.12e-05	CbGpPWpGaD
Chlorprothixene—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.89e-07	1.12e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.87e-07	1.12e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	5.87e-07	1.12e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	5.85e-07	1.12e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	5.85e-07	1.11e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	5.83e-07	1.11e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	5.82e-07	1.11e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	5.8e-07	1.11e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	5.79e-07	1.1e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—JUN—epilepsy syndrome	5.77e-07	1.1e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	5.74e-07	1.09e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	5.71e-07	1.09e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	5.68e-07	1.08e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—JUN—epilepsy syndrome	5.67e-07	1.08e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	5.65e-07	1.08e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	5.63e-07	1.07e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	5.61e-07	1.07e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	5.58e-07	1.06e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	5.52e-07	1.05e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	5.51e-07	1.05e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	5.5e-07	1.05e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	5.48e-07	1.04e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	5.45e-07	1.04e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	5.42e-07	1.03e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—ALB—epilepsy syndrome	5.42e-07	1.03e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	5.36e-07	1.02e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	5.35e-07	1.02e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	5.33e-07	1.02e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	5.31e-07	1.01e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	5.26e-07	1e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—SRC—epilepsy syndrome	5.18e-07	9.87e-06	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	5.09e-07	9.71e-06	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—SRC—epilepsy syndrome	5.08e-07	9.69e-06	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	5.07e-07	9.66e-06	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	5.05e-07	9.63e-06	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	5.04e-07	9.61e-06	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	5e-07	9.53e-06	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	4.96e-07	9.46e-06	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	4.95e-07	9.44e-06	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	4.95e-07	9.44e-06	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	4.93e-07	9.41e-06	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	4.92e-07	9.38e-06	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	4.87e-07	9.29e-06	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—PTGS2—epilepsy syndrome	4.74e-07	9.03e-06	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—AKT1—epilepsy syndrome	4.67e-07	8.9e-06	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	4.52e-07	8.61e-06	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	4.47e-07	8.53e-06	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	4.26e-07	8.12e-06	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	4.2e-07	8.02e-06	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—AKT1—epilepsy syndrome	3.75e-07	7.16e-06	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	3.65e-07	6.95e-06	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	3.22e-07	6.13e-06	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	3.17e-07	6.03e-06	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	3.16e-07	6.02e-06	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	3.15e-07	6e-06	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	3.14e-07	5.98e-06	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	3.11e-07	5.93e-06	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—AKT1—epilepsy syndrome	2.38e-07	4.54e-06	CbGpPWpGaD
